Chronic Kidney Disease Stage 3B
10
1
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
75.0%
-11.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment
Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)
Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease
Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease
Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease
Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2
Effect of a CKD Dashboard on Patient Activation and Shared Decision Making
Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria
Physiopathology of Neuromuscular Function Related to Fatigue in Chronic Renal Disease
Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis